Arvada Dialysis Center (DVA) is a medicare approved dialysis facility center in Arvada, Colorado and it has 16 dialysis stations. It is located in Jefferson county at 9950 W 80th Ave Ste 25, Arvada, CO, 80005. You can reach out to the office of Arvada Dialysis Center (DVA) at (303) 456-9556. This dialysis clinic is managed and/or owned by Davita. Arvada Dialysis Center (DVA) has the following ownership type - Profit. It was first certified by medicare in November, 1995. The medicare id for this facility is 062521 and it accepts patients under medicare ESRD program.
| Name | Arvada Dialysis Center (DVA) |
|---|---|
| Location | 9950 W 80th Ave Ste 25, Arvada, Colorado |
| No. of Dialysis Stations | 16 |
| Medicare ID | 062521 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 9950 W 80th Ave Ste 25, Arvada, Colorado, 80005 | |
| (303) 456-9556 | |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
| NPI Number | 1164899670 |
| Organization Name | Arvada Dialysis Center |
| Doing Business As | Kingston Dialysis Llc |
| Address | 9950 W 80th Ave Ste 25 Arvada, Colorado, 80005 |
| Phone Number | (303) 456-9556 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
| NPI Number | 1245206333 |
| Organization Name | Arvada Dialysis Center |
| Doing Business As | Total Renal Care Of Colorado Inc |
| Address | 9950 W 80th Ave Arvada, Colorado, 80005 |
| Phone Number | (303) 456-9556 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
| NPI Number | 1609037373 |
| Organization Name | Arvada Dialysis Center |
| Doing Business As | Mountain West Dialysis Services Llc |
| Address | 9950 W 80th Ave Arvada, Colorado, 80005 |
| Phone Number | (303) 456-9556 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 9 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 27 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 204 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Arvada Dialysis Center (DVA) with elevated calcium levels.
| Patients with hypercalcemia | 29 |
| Hypercalcemia patient months | 224 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 30 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 34 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 30 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 24 |
| Patient months included in arterial venous fistula and catheter summaries | 144 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 65 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 1 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 21 |
| Hospitalization Rate in facility | 181.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 432.5 |
| Hospitalization Rate: Lower Confidence Limit | 81.3 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Arvada Dialysis Center (DVA) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 33.7 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 49.6 |
| Readmission Rate: Lower Confidence Limit | 19.5 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Arvada Dialysis Center (DVA) get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .93 (As Expected) |
| SIR: Upper Confidence Limit | 4.59 |
| SIR: Lower Confidence Limit | .05 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Arvada Dialysis Center (DVA)'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 18 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Arvada Dialysis Center (DVA) lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 142 |
| Mortality Rate in facility | 19 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 27.5 |
| Mortality Rate: Lower Confidence Limit | 12.6 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago
Arvada Dialysis Center (DVA) Location: 9950 W 80th Ave Ste 25, Arvada, Colorado, 80005 Phone: (303) 456-9556 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.
BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.
The EuroTech Universities Alliance, an international partnership dedicated to producing new knowledge and translating it into action for the benefit of society, will highlight innovations in communication and education as well as technology at the Euroscience Open Forum (ESOF 2014), June 21-26 in Copenhagen, Denmark.
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
Dr. Rama Ranganathan, Director of the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology at UT Southwestern Medical Center, has been awarded a prestigious 2016 Transformative Research Award from the National Institutes of Health's Common Fund.
› Verified 6 days ago